Paul J. Hampel, MD
Advertisement
Articles by Paul J. Hampel, MD
Advertisement
Latest Updated Articles
Real-world treatment patterns and biomarker utilization among patients aged ≥65 years with CLL/SLL from 2020 to 2024Published: January 9th 2026 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
The Role of Elacestrant in ER+/HER2– Advanced Breast Cancer Harboring ESR1 Mutations
2
Nemtabrutinib With Venetoclax Shows Promising Activity in R/R CLL/SLL
3
Maintenance Gemogenovatucel-T Shows Survival Benefit in cTMB-High/HRP Ovarian Cancer
4
Pembrolizumab Fails to Yield Responses in Recurrent Medullary Thyroid Cancer
5